UBS Group
ELAB icon

UBS Group’s Elevai Labs ELAB Stock Holding History

UBS Group’s Portfolio ELAB Stock Details ELAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.8K Buy
1,302
+1,231
+1,734% +$15.8K ﹤0.01% 8550
2025
Q4 		$2.51K Buy
71
+66
+1,320% +$7.84K ﹤0.01% 9293
2025
Q3 		$619 Sell
5
-28
-85% -$4.49K ﹤0.01% 9597
2025
Q2 		$6.07K Buy
33
+15
+83% +$3.24K ﹤0.01% 9117
2025
Q1 		$7.07K Buy
18
+2
+13% +$1.76K ﹤0.01% 8858
2024
Q4 		$20.9K Buy
+16
New +$83.2K ﹤0.01% 7841
2024
Q3 		– Hold
0
– -$4.62K – 9624
2024
Q2 		– Hold
0
– – – 8070
2024
Q1 		– Hold
0
– – – 8317

Other funds holding ELAB

Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return